The cortical cells of mice function in ways that are surprisingly similar to those of humans — it is this similarity that we leverage in the research carried out at the Brain Vision Center Research Institute and Competence Center (BVC). In the Novum programme, which focuses on innovation, science and technology, we presented how our Moculus system supports a deeper understanding of human vision and contributes to the development of new therapeutic options for treating blindness.

Botond Roska, Director of the Institute of Molecular and Clinical Ophthalmology in Basel and co-founder of the BrainVisionCenter in Budapest, gave a lecture at the Budapest University of Technology and Economics, where he serves as a Neumann János Professor. In his presentation titled Restoring Vision, he introduced a new therapeutic approach developed at his institute, which could mark a breakthrough in the treatment of visual impairments. Roska emphasized that the foundation of this therapy lies in basic research that revealed the retina is not merely a light sensor, but a “visual computer” in its own right. Before visual information reaches the brain, the retina processes it through over a hundred types of nerve cells, breaking it down into around 30 components.
Go to the original article: https://index.hu/techtud/2025/06/03/orvostudomany-latas-szem-roska-botond-genterapia-mitokondrium-bme-neumann-professzor/